secwatch.observer — SEC 8-K summary
======================================

Issuer:     SUTRO BIOPHARMA, INC. (STRO)
CIK:        0001382101
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0000950170-24-071335
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Sutro Biopharma stockholders elect Lobacki, Petree; ratify EY; approve say-on-pay & ESPP amendment
--------------------------------------------------------------------------------

- Joseph M. Lobacki re-elected with 49.6M shares For (1.4M Withheld); Daniel H. Petree re-elected with 33.4M For (17.6M Withheld).
- Ernst & Young ratified as independent auditor for FY 2024: 64.6M For, 118.9K Against, 161.9K Abstain.
- Non-binding advisory approval of named executive officer compensation: 50.2M For, 171.2K Against, 587.3K Abstain.
- Amendment to 2018 Employee Stock Purchase Plan approved: 50.2M For, 618.7K Against, 129.4K Abstain (increase share limit + clarifying revisions).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382101/000095017024071335/0000950170-24-071335-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382101/000095017024071335/stro-20240606.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-071335

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer